SymbolAIMD
NameKAINOS GROUP PLC
SectorHEALTH CARE
RegionEurope
Industry-
AddressBT7 1NT United Kingdom 4-6 Upper Crescent
Telephone+44 28 9057 1100
Fax
Email
Websitehttps://investor.kainos.com
IncorporationGB
Incorporated On
Employees
Fiscal Year12/31
Public Since
ExchangesOTC;NASDAQ
Auditor
Audit StatusNOT AVAILABLE
Reporting StatusInternational Reporting: LSE - London Stock Exchange
CIK0001014763
Description

Kainos (ancient Greek meaning new or fresh). Were one of the longest standing independent digital technology companies in the UK. We now have 13 offices across Europe and America. We provide a full lifecycle portfolio of bespoke digital technology solutions to public and private sector customers. We lead the market for the provision of Mobile-Enabled Healthcare solutions to the NHS.

Additional info from NASDAQ:
Ainos, Inc. (NASDAQ AIMD) is a dual platform AI and biotech company pioneering SmellTech, AI diagnostics, and immune therapeutics. Ainos proprietary AI Nose platform uses a breakthrough smell language model (SLM) to digitize scent into Smell IDs, turning invisible chemical signals into machine readable data. From robotics and smart factories to senior care and womens health, Ainos is giving AI the power to smell, unlocking a new frontier in sensory intelligence. With strategic partners, Ainos is scaling the first commercial digital olfaction platform. Ainos also develops VELDONA, a low dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. Multiple clinical programs are in motion Active clinical programs include HIV related oral warts, primary Sjogrens syndrome, and feline chronic gingivostomatitis (FCGS).

Additional info from OTC:
Kainos (ancient Greek meaning new or fresh). Were one of the longest standing independent digital technology companies in the UK. We now have 13 offices across Europe and America. We provide a full lifecycle portfolio of bespoke digital technology solutions to public and private sector customers. We lead the market for the provision of Mobile-Enabled Healthcare solutions to the NHS.

2026-06-09 16:04

Director chiang yao-chung 🟢 acquired 3.5K shares of Ainos, Inc. (AIMD) at $2.05 Transaction Date: Jun 05, 2026 | Filing ID: 027881

Read more
2026-06-05 20:10

Director chiang yao-chung 🟢 acquired 2.0K shares of Ainos, Inc. (AIMD) at $2.13 Transaction Date: Jun 03, 2026 | Filing ID: 027488

Read more
2026-06-01 20:10

Director chiang yao-chung 🟢 acquired 250 shares of Ainos, Inc. (AIMD) at $2.30 Transaction Date: May 28, 2026 | Filing ID: 026617

Read more
2026-05-29 20:10

Director chiang yao-chung 🟢 acquired 2.0K shares of Ainos, Inc. (AIMD) at $2.00 Transaction Date: May 27, 2026 | Filing ID: 026361

Read more
2026-05-28 00:02

Director lee ting-chuan 🔴 sold 110.0K shares of Ainos, Inc. (AIMD) at $1.90 Transaction Date: May 26, 2026 | Filing ID: 025486

Read more
2026-05-28 00:00

Taiwan Carbon Nano Technology Corp 🔴 sold 41.0K shares of Ainos, Inc. (AIMD) at $2.36 Transaction Date: May 26, 2026 | Filing ID: 025484

Read more
2026-05-27 23:58

Director TSAI CHUN-JUNG 🔴 sold 28.8K shares of Ainos, Inc. (AIMD) at $1.87 Transaction Date: May 22, 2026 | Filing ID: 025482

Read more
2026-05-26 20:10

Director lee ting-chuan 🔴 sold 18.3K shares of Ainos, Inc. (AIMD) at $1.57 Transaction Date: May 21, 2026 | Filing ID: 025246

Read more
2026-05-20 20:10

Director chiang yao-chung 🟢 acquired 2.7K shares of Ainos, Inc. (AIMD) at $1.68 Transaction Date: May 18, 2026 | Filing ID: 024604

Read more
2026-05-13 20:30

(19% Negative) KAINOS GROUP PLC (AIMDW) Reports Q2 2026 Financial Results

Read more